Literature DB >> 8335081

Pancreastatin (33-49) enhances the priming effect of glucose in the rat pancreas.

V Sánchez-Margalet1, R Goberna.   

Abstract

Short-term exposure to glucose increases insulin secretion during subsequent stimulation. We investigated the effect of the new regulatory peptide pancreastatin on this priming effect of glucose in the perfused rat pancreas. Pancreastatin (33-49) at a concentration of 10(-8) M inhibited insulin release when stimulated by glucose at a concentration of 16.7 mM. However, after a second pulse of 16.7 mM glucose, pancreastatin potentiated the priming effect of glucose on insulin secretion. The modulation of insulin secretion by pancreastatin results in a potentiation of the priming effect of glucose in the rat pancreas, suggesting a role for pancreastatin in the adaptation of the B cell to glucose-stimulated insulin secretion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8335081     DOI: 10.1007/bf01955161

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  17 in total

1.  Pancreastatin increases cytosolic Ca2+ in insulin secreting RINm5F cells.

Authors:  V Sánchez-Margalet; M Lucas; R Goberna
Journal:  Mol Cell Endocrinol       Date:  1992-10       Impact factor: 4.102

2.  Pancreastatin and its 33-49 C-terminal fragment inhibit glucagon-stimulated insulin in vivo.

Authors:  V Sánchez-Margalet; J R Calvo; M Lucas; R Goberna
Journal:  Gen Pharmacol       Date:  1992-07

3.  Glucogenolytic and hyperglycemic effect of 33-49 C-terminal fragment of pancreastatin in the rat in vivo.

Authors:  V Sánchez-Margalet; J R Calvo; R Goberna
Journal:  Horm Metab Res       Date:  1992-10       Impact factor: 2.936

4.  Pancreastatin inhibits insulin release from Rin m 5F cells: reversion by pertussis toxin.

Authors:  A M Lorinet; K Tatemoto; M Laburthe; B Amiranoff
Journal:  Eur J Pharmacol       Date:  1989-02-07       Impact factor: 4.432

5.  Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion.

Authors:  K Tatemoto; S Efendić; V Mutt; G Makk; G J Feistner; J D Barchas
Journal:  Nature       Date:  1986 Dec 4-10       Impact factor: 49.962

6.  Time and dose dependencies for priming effect of glucose on insulin secretion.

Authors:  V Grill
Journal:  Am J Physiol       Date:  1981-01

7.  Pancreastatin, a presumed product of chromogranin-A (secretory protein-I) processing, inhibits secretion from porcine parathyroid cells in culture.

Authors:  B H Fasciotto; S U Gorr; D J DeFranco; M A Levine; D V Cohn
Journal:  Endocrinology       Date:  1989-09       Impact factor: 4.736

8.  GTP-dependent inhibition of insulin secretion by epinephrine in permeabilized RINm5F cells. Lack of correlation between insulin secretion and cyclic AMP levels.

Authors:  S Ullrich; C B Wollheim
Journal:  J Biol Chem       Date:  1988-06-25       Impact factor: 5.157

9.  Expression of both alpha 1- and alpha 2-adrenoceptors in an insulin-secreting cell line. Parallel studies of cytosolic free Ca2+ and insulin release.

Authors:  S Ullrich; C B Wollheim
Journal:  Mol Pharmacol       Date:  1985-08       Impact factor: 4.436

10.  The priming effect of glucose on insulin secretion from isolated islets of Langerhans.

Authors:  J P Ashby; D Shirling
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.